Structure Therapeutics (GPCR) valuation check after Phase 1 obesity candidate ACCG-2671 enters first-in-human trial [Yahoo! Finance]
Structure Therapeutics Inc. - American Depositary Shares (GPCR)
Company Research
Source: Yahoo! Finance
See our latest analysis for Structure Therapeutics. The Phase 1 launch for ACCG-2671 comes after a sharp re-rating in Structure Therapeutics, with an 84 percent 1 month share price return feeding into a 163 percent 3 month share price return and 121 percent 1 year total shareholder return. This signals that momentum is still building at a 63.25 dollars share price. If this obesity story has caught your attention, it could be worth scanning other innovative biotechs by exploring healthcare stocks as potential additions to your watchlist. With shares already up more than 160 percent over three months but still trading at a steep discount to analyst targets, is Structure Therapeutics an obesity innovator still mispriced, or is the market already factoring in future growth? On a price-to-book basis, Structure Therapeutics trades around 5 times book value, which puts a premium valuation on the 63.25 dollars share price. The price-to-book ratio compares a company's market value t
Show less
Read more
Impact Snapshot
Event Time:
GPCR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GPCR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GPCR alerts
High impacting Structure Therapeutics Inc. - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
GPCR
News
- Obesity stocks slump on Novo's underwhelming 2026 sales forecast [Yahoo! Finance Canada]Yahoo! Finance Canada
- Key deals this week: Apple, McEwen Mining, IonQ, Leidos, and more [Seeking Alpha]Seeking Alpha
- Structure Therapeutics (NASDAQ:GPCR) was downgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=GPCR&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall MarketBeat
- Structure Therapeutics (NASDAQ:GPCR) had its "sell (d-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Structure Therapeutics (NASDAQ:GPCR) was upgraded by analysts at The Goldman Sachs Group, Inc. to a "strong-buy" rating.MarketBeat
GPCR
Sec Filings
- 2/5/26 - Form SCHEDULE
- 1/20/26 - Form 4
- 1/5/26 - Form 8-K
- GPCR's page on the SEC website